Malaria vaccine displays 100% success rate in clinical trial
February 16, 2017Research and Development Vaccine, malaria
A malaria vaccine, jointly developed by the University of Tübingen and biotech company Sanaria Inc., has demonstrated in a small pool …
Dr Reddy’s rocked by negative patent infringement ruling, shares hit one-year low
February 16, 2017Sales and Marketing Dr Reddy's Laboratories, Helsinn Healthcare
India-based pharmaceutical firm Dr Reddy’s Laboratories has been hit by an unfavourable ruling in a legal case claiming it infringed …
FDA approves Valeant plaque psoriasis drug despite suicide concerns
February 16, 2017Sales and Marketing FDA, Siliq, Valeant, psoriasis
The US Food and Drug Administration (FDA) has announced that it has approved Valeant Pharmaceutical’s injectable psoriasis treatment Siliq (brodalumab) …
Integra bids $1.045 billion for J&J’s neurosurgery business
February 16, 2017Sales and Marketing Codman, Integra, J&J, JJ, Johnson & Johnson
Integra, a medical technology company, have announced that it has made a binding offer to acquire Johnson & Johnson’s Codman …
Woodley Equipment Company Exhibiting at Outsourcing in Clinical Trials West Coast 2017
February 15, 2017Lab Equipment supplier, Medical Equipment Supplier, medical equipment
The Clinical Trials Team at Woodley Equipment Company is exhibiting at Outsourcing in Clinical Trials West Coast 2017 which is taking place …
New cancer drug could give hope to non-responsive patients
February 15, 2017Research and Development Cancer
A new dual action drug developed as part of a collaboration between biopharmaceutical oncology firm Almac Discovery and The Royal …
Stada encourages bidding war, with figure of €3.5 billion mooted
February 15, 2017Research and Development, Sales and Marketing Advent International, Cinven, Stada
Stada, the German generic drugmaker, has received two offers for takeover, with one estimated to be €3.5 billion, thought to …
US panel endorses human embryo gene editing, with caveats
February 15, 2017Research and Development crispr, gene editing
Gene editing in human embryos has been given the go-ahead by a panel of experts from the US National Academy …
MSD’s Alzheimer’s drug failure undermines potential treatment pathway
February 15, 2017Research and Development Alzheimer's, MSD, Merck
MSD, known as Merck in North America, has announced that it has been forced to cancel a Phase 2/3 trial …
Magnetic implant could revolutionise drug delivery
February 15, 2017Research and Development University of British Colombia, University of British Colombia - Device next to Canadian one dollar coin., magnetic implant
Researchers from the University of British Columbia have invented a new method of drug delivery that relies on magnets to …
Plastic electronics to bring “mind-blowing” developments for pharma
February 14, 2017Manufacturing and Production, Research and Development plastic electronics
Plastic electronics could be the next big thing for pharma production and treatment , according to a new report on …
Hepatitis C market set for slump as cure rates rise
February 14, 2017Manufacturing and Production, Medical Communications, Sales and Marketing Gilead, hepatitis C
Objectively, it is the pharmaceutical industries intention to find cures for diseases and to aid patients to live a full …
GSK unveils strong showing for twin-drug HIV treatment
February 14, 2017Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, HIV, Tivicay
GlaxoSmithKline has announced strong Phase 3 findings for its own Tivicay (dolutegravir) as part of a twin-drug regimen with J&J’s …
Marathon’s major misstep shows that drug pricing debate is here to stay
February 14, 2017Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Emflaza, marathon
Marathon Pharmaceuticals’ approval, last week, by the FDA for its treatment for Duchenne muscular dystrophy would usually have been cause …
Allergan set to bolster ‘medical aesthetics’ unit with $2.5 billion Zeltiq deal
February 13, 2017Manufacturing and Production, Sales and Marketing Allergan, FDA, Zeltiq
Allergan, the owner of Botox, has expanded its stake in the ‘medical aesthetics’ business by acquiring Zeltiq Aesthetics. Zeltiq has …
Pfizer and Flynn: How are ‘excessive’ prices for generic drugs possible and should competition authorities do more about exploitative pricing?
February 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, Pfizer, flynn
As last year came to a close, the headlines were rocked by the news that pharma giant Pfizer had been …
NICE turns down AZ’s chronic obstructive pulmonary disease drug
February 13, 2017Sales and Marketing AstraZeneca, Daxas, NICE, chronic obstructive pulmonary disease
AstraZeneca’s Daxas (roflumilast) has been knocked back in draft guidance by the National Institute for Health and Care Excellence (NICE), …
Lilly €200m expansion of Cork site under review
February 13, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Ireland, cork
Eli Lilly’s planned €200m investment to its manufacturing plant in Kindsdale, County Cork, is now under-review. The expansion would bring …
Ipsen to acquire Sanofi assets in $88 million deal
February 13, 2017Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen
Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …
First-ever approved fertility app more effective than the pill, experts say
February 13, 2017Research and Development, Sales and Marketing contraception
Fertility app Natural Cycles has become the first-ever smartphone application and software solution to be approved by experts as a …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
